相似文献
1
Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf-Induced Tumorigenesis.
Cancer Cell. 2019 Feb 11;35(2):315-328.e6. doi: 10.1016/j.ccell.2019.01.005.
2
DNA methylation instability by BRAF-mediated TET silencing and lifestyle-exposure divides colon cancer pathways.
Clin Epigenetics. 2019 Dec 16;11(1):196. doi: 10.1186/s13148-019-0791-1.
3
Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling.
PLoS One. 2009 Dec 21;4(12):e8357. doi: 10.1371/journal.pone.0008357.
4
BRAF drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation.
Oncogene. 2020 Sep;39(38):6053-6070. doi: 10.1038/s41388-020-01414-9. Epub 2020 Aug 13.
5
Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer.
Mod Pathol. 2011 Mar;24(3):396-411. doi: 10.1038/modpathol.2010.212. Epub 2010 Nov 19.
6
BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
Am J Surg Pathol. 2012 May;36(5):744-52. doi: 10.1097/PAS.0b013e31824430d7.
7
Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
Int J Cancer. 2014 May 15;134(10):2342-51. doi: 10.1002/ijc.28564. Epub 2013 Nov 13.
8
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
Gastroenterology. 2015 Jan;148(1):88-99. doi: 10.1053/j.gastro.2014.09.041. Epub 2014 Oct 8.
9
Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer.
Mod Pathol. 2011 Jul;24(7):1015-22. doi: 10.1038/modpathol.2011.43. Epub 2011 Mar 18.
10
The BRAF(V600E) causes widespread alterations in gene methylation in the genome of melanoma cells.
Cell Cycle. 2012 Jan 15;11(2):286-95. doi: 10.4161/cc.11.2.18707.
引用本文的文献
1
Unravelling the genetics and epigenetics of the ageing tumour microenvironment in cancer.
Nat Rev Cancer. 2025 Sep 8. doi: 10.1038/s41568-025-00868-x.
2
Restoring resident tissue macrophages to combat aging and cancer.
Nat Aging. 2025 Aug;5(8):1383-1392. doi: 10.1038/s43587-025-00898-y. Epub 2025 Aug 14.
3
Colonic Aging and Colorectal Cancer: An Unignorable Interplay and Its Translational Implications.
Biology (Basel). 2025 Jul 3;14(7):805. doi: 10.3390/biology14070805.
4
BRAF augments WNT signaling in colorectal cancer via aberrant DNA methylation.
iScience. 2025 May 20;28(7):112708. doi: 10.1016/j.isci.2025.112708. eCollection 2025 Jul 18.
5
BRAF maintains the CpG island methylator phenotype, and DNA methylation of PRC2 targets genes in colon cancer.
iScience. 2025 Jun 14;28(7):112905. doi: 10.1016/j.isci.2025.112905. eCollection 2025 Jul 18.
6
Modelling the ageing dependence of cancer evolutionary trajectories.
Nat Rev Cancer. 2025 Jul 10. doi: 10.1038/s41568-025-00838-3.
7
Simulation-guided pan-cancer analysis identifies a novel regulator of CpG island hypermethylation heterogeneity.
Brief Bioinform. 2025 May 1;26(3). doi: 10.1093/bib/bbaf252.
8
Genome-wide DNA methylation status as a biomarker for clinical outcomes of first-line treatment in patients with RAS wild-type metastatic colorectal cancer: JACCRO CC-13AR.
ESMO Open. 2025 May 6;10(5):105076. doi: 10.1016/j.esmoop.2025.105076.
9
Comprehensive metabolomic and epigenomic characterization of microsatellite stable BRAF-mutated colorectal cancer.
Oncogene. 2025 Mar 18. doi: 10.1038/s41388-025-03326-y.
10
Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapy.
Nat Commun. 2025 Jan 8;16(1):474. doi: 10.1038/s41467-024-55481-7.
本文引用的文献
1
DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk.
Cancer Cell. 2018 Feb 12;33(2):309-321.e5. doi: 10.1016/j.ccell.2018.01.008.
2
Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer.
Cell Rep. 2017 Dec 26;21(13):3833-3845. doi: 10.1016/j.celrep.2017.11.104.
3
Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer.
Science. 2017 Oct 13;358(6360):234-238. doi: 10.1126/science.aao3130. Epub 2017 Sep 14.
4
Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations.
Cancer Cell. 2017 Sep 11;32(3):360-376.e6. doi: 10.1016/j.ccell.2017.08.006.
5
CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes.
Cancer Cell. 2017 May 8;31(5):653-668.e7. doi: 10.1016/j.ccell.2017.04.005.
6
Using DNA Methylation Profiling to Evaluate Biological Age and Longevity Interventions.
Cell Metab. 2017 Apr 4;25(4):954-960.e6. doi: 10.1016/j.cmet.2017.03.016.
7
Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system.
Br J Cancer. 2017 Apr 11;116(8):1012-1020. doi: 10.1038/bjc.2017.52. Epub 2017 Mar 9.
8
BRAF cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis.
Elife. 2017 Jan 10;6:e20331. doi: 10.7554/eLife.20331.
9
Correlation of an epigenetic mitotic clock with cancer risk.
Genome Biol. 2016 Oct 3;17(1):205. doi: 10.1186/s13059-016-1064-3.
10
Organoids: Modeling Development and the Stem Cell Niche in a Dish.
Dev Cell. 2016 Sep 26;38(6):590-600. doi: 10.1016/j.devcel.2016.08.014.
Zotero 插件